RM30.6 billion – that’s the amount that the Malaysian government collected from excise taxes on cigarettes, tobacco products and alcohol, from 2012 to 2017.  Compare that to the ever-increasing cost of treating non-communicable diseases like cancer, diabetes and cardiovascular diseases, which is placing enormous pressure on public funds, as well as individuals’ private savings. With concerns that the COVID-19 pandemic will divert already scarce resources from preventive health programmes, we explore whether Malaysia should earmark the billions of ringgit collected from alcohol and tobacco taxes annually to fund public health.

Image source: Shutterstock

Produced by: Janese Wong & Tee Shiao Eek

Presented by: Tee Shiao Eek

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  The Bigger Picture,  Health & Living,  non-communicable diseases,  alcohol,  smoking,  healthcare cost,  tax,  Government/Regulatory/Policy Making,  Healthcare, Pharma, Biotech,  Other personality interviews,  Health,  Health Policy,  Diseases & Conditions,  Mental Health,  Healthy Living,  Fitness,  Medical Innovation and Technology,  Politics,  law & legal matters,  Science